---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-091829"
form_type: "8-K"
ticker: "HYPD"
cik: "0001682639"
company_name: "HYPERION DEFI, INC."
filed_at: "2024-08-22T23:59:59+00:00"
generated_at: "2026-05-31T08:05:20.072238+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Eyenovia prices public offering of 12.85M shares at $0.40 for ~$5.14M gross proceeds

## Summary
- Priced 12,850,000 common shares at $0.40 per share; expected to close August 22, 2024.
- Gross proceeds of approximately $5.14 million before fees and expenses.
- Proceeds to fund Mydcombi and clobetasol propionate commercialization, CHAPERONE pediatric myopia study, and general corporate purposes.
- May also repay portion of existing indebtedness under Loan and Security Agreement with Avenue Capital Management.
- Dawson James Securities acting as sole placement agent; offering made under existing S-3 shelf registration.

## SEC filing metadata
- accession: 0001104659-24-091829
- form_type: 8-K
- ticker: HYPD
- cik: 0001682639
- company_name: HYPERION DEFI, INC.
- filed_at: 2024-08-22T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682639/000110465924091829/0001104659-24-091829-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682639/000110465924091829/tm2422365d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-091829
- JSON: https://secwatch.observer/filing/0001104659-24-091829.json
- Plain text: https://secwatch.observer/filing/0001104659-24-091829.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.